Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Co-Led by Acre Venture Partners and Corteva

Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Co-Led by Acre Venture Partners and Corteva

ITHACA, N.Y.--(BUSINESS WIRE)--Oct 14, 2025-

Corteva co-leads backing of Ascribe Bio in $12M Series A funding

Ascribe Bio, a New York-based agricultural technology company focused on natural crop protection, has closed a $12 million Series A financing round, co-led by Corteva, through its Corteva Catalyst platform, and Acre Venture Partners. The financing also included participation from new and existing investors including Syngenta Group Ventures, Trailhead Capital, Silver Blue, Cultivation Capital and the Yield Lab. This…